SCHEMBL24966779

SCHEMBL24966779

C[C@H](c1ccccc1)n1nnc(F)c1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
BRD4 O60885 2/20 0.41
ATM Q13315 4/20 0.39
FAAH O00519 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
CASP1 P29466 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CLK1 P49759 1/20 0.36
CYP2D6 P10635 1/20 0.36
KDM5A P29375 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
ROCK2 O75116 1/20 0.36
MAOA P21397 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23234260 1.00 ALDH1A1 (0.42) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24966194 0.90 BRD4 (0.40) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24966219 0.86 BRD4 (0.40) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24966734 0.86 PDCD1 (0.40) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24967057 0.86 BRD4 (0.38) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24966999 0.85 BRD4 (0.37) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24966776 0.84 CYP1A2 (0.51) ALDH1A1KDM4ELMNAHSD17B10HPGD
SCHEMBL24966742 0.84 BRD4 (0.36) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24966901 0.82 ALDH1A1 (0.42) ALDH1A1TDP1BRD4ATMFAAH
SCHEMBL24966146 0.82 ALDH1A1 (0.42) ALDH1A1TDP1BRD4ATMFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CYP21A2, CYP11B1, CYP11B2 ALDH1A1 413/4885TDP1 3560/4885BRD4 2260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.